Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FDADH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,488
Award facts
- Contract value 100% obligated
- $16,487.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Dupixent 300 mg/2 mL pen injectors, with a contract ceiling value of $16,487.50 under a firm fixed price arrangement. This non-set-aside competitive award was executed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, eosinophilic esophagitis, and certain asthma phenotypes, representing a specialty pharmaceutical product aligned with military and federal healthcare supply requirements.
This delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor contract running through December 2026 that provides global pharmaceutical support across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical devices through competitively awarded DLA contracts, demonstrating its capability to fulfill specialized pharmaceutical procurement needs for the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDADH?
SPE2DB25FDADH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FDADH worth?
The government has obligated $16,488 on SPE2DB25FDADH.
Is contract SPE2DB25FDADH an order under another contract?
Yes. SPE2DB25FDADH is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDADH competed?
The extent of competition for SPE2DB25FDADH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award